Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients
Award Notice Posted
- Solicitation number
- 75N91021R00007
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- Multiple_Contracts-See_Below
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
Notice text
A Multiple-Award Indefinite Delivery, Indefinite Quantity (IDIQ) contract was awarded to each of the following
organizations in support of the Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients Program under this RFP no. 75N91021R00007.
75N91021D00019 - University of Pittsburgh (Pittsburgh, PA) - awarded 9/24/2021
75N91021D00020 - Mayo Clinic (Rochester, MN) - awarded 9/23/2021
75N91021D00021 - SRI International (Menlo Park, CA) - awarded 9/23/2021
Awarded contract Multiple_Contracts-See_Below to Multiple_Contracts-See_Below for 9900000.00 on 2021-09-24.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients | Solicitation | |
| Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients | Pre-Solicitation | |
| Preclinical Pharmacokinetic and Pharmacology Evaluations of | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity